Surgi-Vision has received Food and Drug Administration 510(k) clearance for its Intercept - Prostate micro-coil. Intercept will join two other FDA-cleared coils, Intercept – Esophagus and Intercept – Urethra, in the Columbia, MD-based firm’s product line of internal MRI micro-coils.
Surgi-Vision’s technology was developed in coordination with biomedical engineers and radiologists from Johns Hopkins University School of Medicine in Baltimore.
By AuntMinnie.com staff writers
December 1, 2000
Related Reading
Surgi-Vision wins clearance for MRI coil, October 26, 2000
Copyright © 2000 AuntMinnie.com
